dual glp-1/gip receptor agonists Potential Use of GLP-1 and GIP/GLP-1 for Respiratory Disorders: Where Are We at? Dual GIP–GLP1-Receptor Agonists In The
Description
Patients should be aware of the risk of diabetic retinopathy complications , particularly with semaglutide, especially in those with pre-existing retinopathy and rapid improvements in blood glucose

Therapeutic effects become pronounced

World Journal of Clinical Cases, 3 (7), 640649

Mitchell JL, Mollan SP, Vijay V, Sinclair AJ

At last there is a promising treatment for this chronic disease FDA-approved GLP-1 Anti-Obesity Medication (AOM) such as Wegovy and Saxenda but the cost implications are concerning
Table 2 This table compiles current knowledge evaluating the impact of GLP-1 RAs on disease outcomes and safety in IBD patients
